<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>药融圈 | wechat-feeds</title><link>http://MzUyNTgyNjUzMw.favicon.privacyhide.com/favicon.ico</link><description>药融圈PHARNEX汇聚数万医药大咖，得到数千家医药创业者鼎力支持，开展日常专题讲座。致力于成为“专业、前沿、权威、严谨”的医药行业资讯平台，以及项目、技术、工厂、融资、股权投资等资源整合平台。欢迎您关注药融圈，共同碰撞“药”的火花!</description><managingEditor> (hellodword)</managingEditor><pubDate>Wed, 10 Feb 2021 11:51:16 +0800</pubDate><image><url>http://MzUyNTgyNjUzMw.favicon.privacyhide.com/favicon.ico</url><title>药融圈 | wechat-feeds</title><link>http://MzUyNTgyNjUzMw.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>高端制剂：则正医药，获晨兴亿元战略投资</title><link>https://mp.weixin.qq.com/s/ESnc5ZlV_Ck2mPxg8V0Cow</link><description></description><content:encoded><![CDATA[高端制剂：则正医药，获晨兴亿元战略投资]]></content:encoded><pubDate>Tue, 09 Feb 2021 21:10:08 +0800</pubDate></item><item><title>火热报名中：大湾区(广州)生物医药创新者峰会来袭</title><link>https://mp.weixin.qq.com/s/YDJ04Pi30M0RVAmK2uz_Wg</link><description></description><content:encoded><![CDATA[火热报名中：大湾区(广州)生物医药创新者峰会来袭]]></content:encoded><pubDate>Tue, 09 Feb 2021 21:10:08 +0800</pubDate></item><item><title>恒瑞医药与璎黎药业签订战略合作协议，合力攻坚肿瘤新疗法</title><link>https://mp.weixin.qq.com/s/DpwV0LdGSMs2sE6zMDuiZQ</link><description></description><content:encoded><![CDATA[恒瑞医药与璎黎药业签订战略合作协议，合力攻坚肿瘤新疗法]]></content:encoded><pubDate>Tue, 09 Feb 2021 21:10:08 +0800</pubDate></item><item><title>火了！百余个品种过评，注射剂超50%，齐鲁、科伦、人福医药位居前三甲</title><link>https://mp.weixin.qq.com/s/yc9MlKBQT75mdx7ixYbDaw</link><description></description><content:encoded><![CDATA[火了！百余个品种过评，注射剂超50%，齐鲁、科伦、人福医药位居前三甲]]></content:encoded><pubDate>Tue, 09 Feb 2021 21:10:08 +0800</pubDate></item><item><title>改良型新药临床怎么做？CDE发布《化学药品改良型新药临床试验技术指导原则》，即日施行！</title><link>https://mp.weixin.qq.com/s/whFrpqrpOcS7PZMwh6EyTg</link><description></description><content:encoded><![CDATA[改良型新药临床怎么做？CDE发布《化学药品改良型新药临床试验技术指导原则》，即日施行！]]></content:encoded><pubDate>Tue, 09 Feb 2021 21:10:08 +0800</pubDate></item><item><title>他来了他来了！NMPA发布寒假作业！一大批指导原则发布！</title><link>https://mp.weixin.qq.com/s/14CW_GKQYN05DmjXWTixyA</link><description></description><content:encoded><![CDATA[他来了他来了！NMPA发布寒假作业！一大批指导原则发布！]]></content:encoded><pubDate>Tue, 09 Feb 2021 21:10:08 +0800</pubDate></item><item><title>又一项目被砍，赛诺菲终止venglustat帕金森症II期临床试验</title><link>https://mp.weixin.qq.com/s/NDs5sOCg8LeZPB0Xei0nlQ</link><description></description><content:encoded><![CDATA[又一项目被砍，赛诺菲终止venglustat帕金森症II期临床试验]]></content:encoded><pubDate>Tue, 09 Feb 2021 21:10:08 +0800</pubDate></item><item><title>君实生物迎来重磅出海：以创新为驱动，立足本土，布局全球</title><link>https://mp.weixin.qq.com/s/I55f66nuKi0sTf3OhhBxTA</link><description></description><content:encoded><![CDATA[君实生物迎来重磅出海：以创新为驱动，立足本土，布局全球]]></content:encoded><pubDate>Tue, 09 Feb 2021 10:27:53 +0800</pubDate></item><item><title>保诺-桑迪亚宣布新任首席执行官任命--董海军将领导CRDMO 开启下一发展阶段</title><link>https://mp.weixin.qq.com/s/R1htfG8LDMHxMoBPZAASAQ</link><description></description><content:encoded><![CDATA[保诺-桑迪亚宣布新任首席执行官任命--董海军将领导CRDMO 开启下一发展阶段]]></content:encoded><pubDate>Tue, 09 Feb 2021 10:27:53 +0800</pubDate></item><item><title>火热报名中：大湾区(广州)生物医药创新者峰会来袭</title><link>https://mp.weixin.qq.com/s/csmfFRSz5xXGQtFXJkd87A</link><description></description><content:encoded><![CDATA[火热报名中：大湾区(广州)生物医药创新者峰会来袭]]></content:encoded><pubDate>Tue, 09 Feb 2021 10:27:53 +0800</pubDate></item><item><title>110款创新药来袭！40个品种首仿过评，科伦、齐鲁、人福医药...大丰收</title><link>https://mp.weixin.qq.com/s/JvN2bcyXrxHlLu2AzjAMpw</link><description></description><content:encoded><![CDATA[110款创新药来袭！40个品种首仿过评，科伦、齐鲁、人福医药...大丰收]]></content:encoded><pubDate>Tue, 09 Feb 2021 10:27:53 +0800</pubDate></item><item><title>从小众到大众→通用CAR-T未来已来</title><link>https://mp.weixin.qq.com/s/Eu35NCk-WazSAQtyJRvjUg</link><description></description><content:encoded><![CDATA[从小众到大众→通用CAR-T未来已来]]></content:encoded><pubDate>Tue, 09 Feb 2021 10:27:53 +0800</pubDate></item><item><title>默沙东公布2020年业绩：全年营收480亿美元，K药销售额再增长30%</title><link>https://mp.weixin.qq.com/s/LmcY03IiPw_P3JZhqrsvuw</link><description></description><content:encoded><![CDATA[默沙东公布2020年业绩：全年营收480亿美元，K药销售额再增长30%]]></content:encoded><pubDate>Tue, 09 Feb 2021 10:27:53 +0800</pubDate></item><item><title>41.03万美元，“最安全”CAR-T疗法不便宜</title><link>https://mp.weixin.qq.com/s/8Dj5iHSfRoDSVGuEd7rSIA</link><description></description><content:encoded><![CDATA[41.03万美元，“最安全”CAR-T疗法不便宜]]></content:encoded><pubDate>Tue, 09 Feb 2021 10:27:53 +0800</pubDate></item><item><title>新春独家：跨国药企在华研发中心现在都在做什么？</title><link>https://mp.weixin.qq.com/s/0jPMS1mlo5Ur5ok3fezQ8A</link><description></description><content:encoded><![CDATA[新春独家：跨国药企在华研发中心现在都在做什么？]]></content:encoded><pubDate>Sun, 07 Feb 2021 23:33:42 +0800</pubDate></item><item><title>靶点药讯47|纵览全球药物靶点动态</title><link>https://mp.weixin.qq.com/s/l46EvRUeQXs2s2SPYotsbQ</link><description></description><content:encoded><![CDATA[靶点药讯47|纵览全球药物靶点动态]]></content:encoded><pubDate>Sun, 07 Feb 2021 23:33:42 +0800</pubDate></item><item><title>信达，再鼎之后，岸迈生物LAG-3/PD-1双抗EMB-02获批临床</title><link>https://mp.weixin.qq.com/s/jGR-uRNFDDlJfqAjlEplrQ</link><description></description><content:encoded><![CDATA[信达，再鼎之后，岸迈生物LAG-3/PD-1双抗EMB-02获批临床]]></content:encoded><pubDate>Sun, 07 Feb 2021 23:33:42 +0800</pubDate></item><item><title>阿斯利康durvalumab在头颈癌中未达标，中国死亡率达52%</title><link>https://mp.weixin.qq.com/s/c6lOF-inCexyTaJRS7vvWw</link><description></description><content:encoded><![CDATA[阿斯利康durvalumab在头颈癌中未达标，中国死亡率达52%]]></content:encoded><pubDate>Sun, 07 Feb 2021 23:33:42 +0800</pubDate></item><item><title>仅用 3 天！国内第2款新冠疫苗获批；第4批国采本周落幕；海思科新药环泊酚注射液新适应症获批</title><link>https://mp.weixin.qq.com/s/gLYiYU_c6cxhpHpoCCKT-A</link><description></description><content:encoded><![CDATA[仅用 3 天！国内第2款新冠疫苗获批；第4批国采本周落幕；海思科新药环泊酚注射液新适应症获批]]></content:encoded><pubDate>Sun, 07 Feb 2021 23:33:42 +0800</pubDate></item><item><title>速报 | 重磅PI3K抑制剂Umbralisib获FDA加速批准，边缘区和滤泡性淋巴瘤患者迎来福音</title><link>https://mp.weixin.qq.com/s/L7JDkQzVLWxgqX53P6Akxg</link><description></description><content:encoded><![CDATA[速报 | 重磅PI3K抑制剂Umbralisib获FDA加速批准，边缘区和滤泡性淋巴瘤患者迎来福音]]></content:encoded><pubDate>Sun, 07 Feb 2021 23:33:42 +0800</pubDate></item></channel></rss>